CHIPPS WP5: Feasibility Study
Research type
Research Study
Full title
Care Homes Independent Pharmacist Prescribing Service (CHIPPS): Development and delivery of a cluster randomised controlled trial to determine both its effectiveness and cost-effectiveness. Work Package 5: Feasibility Study
IRAS ID
206970
Contact name
David Wright
Contact email
Sponsor organisation
Norfolk & Suffolk Primary & Community Care Research Office, hosted by South Norfolk CCG
ISRCTN Number
ISRCTN00132144
Duration of Study in the UK
1 years, 1 months, 5 days
Research summary
The use of medicines in care homes could be improved and as a result the health of residents would be better. Pharmacist prescribers (i.e. pharmacists specifically accredited to prescribe in a similar way to doctors), have already been shown to provide high quality care, which is safe and well received. We propose to test if making ‘pharmacist prescribers’ part of the care home team, working alongside general practitioners, could improve the use of medicines and the care of residents. These pharmacist prescribers would sign and order monthly prescriptions whilst carefully monitoring how each resident responds. We believe that such a change to the management of medicines in care homes is likely to be a good use of NHS money. However, to develop and test this idea in the best way possible we need to undertake six inter-linked work packages(WP). This application is for WP5 of this programme which is a feasibility study which will test delivery of the new service in preparation for a later formal randomised controlled trial (WP6 of the programme).
REC name
East of England - Essex Research Ethics Committee
REC reference
16/EE/0284
Date of REC Opinion
5 Sep 2016
REC opinion
Further Information Favourable Opinion